Ashley Hume is a seasoned leader with 25 years of experience in the health care and managed care industries, specializing in cost containment, risk projection, and reimbursement strategies for high-cost therapies. As President of Emerging Therapy Solutions (ETS), she oversees the organization’s strategic direction, market strategy, and client-facing teams, ensuring innovative solutions for managing catastrophic claims.

Ashley is an active voice in national policy discussions, serving on multiple committees focused on reimbursement policy and innovative payment strategies for cell & gene therapy. Prior to ETS, she held leadership roles at both a health plan and a health plan services company, as well as senior positions in revenue cycle and contracting for large specialty groups and health systems. Her expertise spans prior authorization, claims and patient financial services, and third-party payor, direct-to-employer, and physician services contracting.